Novartis

Released by CenturyLink...

January 22, 2011 / Jerome / Unclassified / 2 Comments

The portfolio suffered a drop in profitability to -4.74% following the fall of CenturyLink, but maintained a solid performance in euros with a Sharpe ratio higher than the benchmark indices. Dividends continue to rise, and new stocks such as Novartis and Roche are now being monitored to diversify the portfolio.

Released by CenturyLink... Read More »

Novartis (VTX:NOVN)

January 16, 2011 / Jerome / Analysis / Leave a Comment

The merger of Ciba-Geigy and Sandoz in 1996 gave rise to Novartis, now the world's 3rd largest pharmaceutical group. Despite its relative youth, the Basel-based company presents an attractive profile for investors, with a dividend yield of 3% and steadily increasing payouts.

Novartis (VTX:NOVN) Read More »

Clément Christiane on Test de Holland (RIASEC): “It's a quick and easy questionnaire” Jan 6, 2:30 p.m.
Jérôme on Qu’est-ce qui fonctionne à Paris : le Price-Earnings Ratio: “Hello HD, As they often say: "the devil is in the details". I myself was surprised by the…” Jan 5, 08:40
HD on Qu’est-ce qui fonctionne à Paris : le Price-Earnings Ratio: “Hello, In your book, in the section "price/earnings ratio", you write that buying companies with low P/E ratios is a…” Jan 4, 16:43
Jérôme on La marge brute: indicateur clé des actions FR-CH?: “Hi Pedro, this is a very good question that I will answer in the next articles of this backtest series.” Dec 22, 16:44
Pedro on La marge brute: indicateur clé des actions FR-CH?: “What about net margin, EBITDA or other for the same purpose? Or is it gross margin growth that is…” Dec 22, 15:43